Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer

NCT06956976 · Fudan University · Updated 4 May 2025

What is being tested
Dissection of Inferior Mesenteric Artery Root Lymph Node; Preservation of Inferior Mesenteric Artery Root Lymph Node
For
Rectal Cancer
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 1,596 people. The full rules are on the registry page.
Where
China
When
Starts or started 1 June 2025, ends 1 June 2031. Registered 4 May 2025.
Results
None posted yet.

In the researchers' words

In this study, patients with middle or low rectal cancer will receive robotic radical resection, and will be randomly assigned to receive inferior mesenteric artery lymph nodes dissection or preservation. The 3-year disease-free survival rates of these two surgical approaches will be compared.
ClinicalTrials.gov, NCT06956976

Sites

  • Zhongshan Hospital Fudan UniversityShanghai, Shanghai Municipality, China